AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
9.63
-0.04 (-0.41%)
Feb 21, 2025, 4:00 PM EST - Market closed
AlloVir Market Cap
AlloVir has a market cap or net worth of $47.92 million as of February 21, 2025. Its market cap has decreased by -37.24% in one year.
Market Cap
47.92M
Enterprise Value
-73.93M
1-Year Change
-37.24%
Ranking
Category
Stock Price
$9.63
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.43B to $47.92M, a decrease of -96.66%. That is a compound annual growth rate of -52.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 47.92M | -0.31% |
| Dec 31, 2024 | 48.07M | -36.10% |
| Dec 29, 2023 | 75.22M | -83.78% |
| Dec 30, 2022 | 463.83M | -42.20% |
| Dec 31, 2021 | 802.46M | -66.14% |
| Dec 31, 2020 | 2.37B | 65.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |